Cravens & CO Advisors, LLC Abb Vie Inc. Transaction History
Cravens & CO Advisors, LLC
- $129 Billion
- Q3 2024
A detailed history of Cravens & CO Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Cravens & CO Advisors, LLC holds 4,862 shares of ABBV stock, worth $860,330. This represents 0.74% of its overall portfolio holdings.
Number of Shares
4,862
Previous 6,903
29.57%
Holding current value
$860,330
Previous $1.18 Billion
18.91%
% of portfolio
0.74%
Previous 0.88%
Shares
8 transactions
Others Institutions Holding ABBV
# of Institutions
3,848Shares Held
1.25BCall Options Held
16.8MPut Options Held
12.2M-
Vanguard Group Inc Valley Forge, PA172MShares$30.4 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY136MShares$24.1 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.1MShares$14 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY52.1MShares$9.22 Billion0.84% of portfolio
-
Morgan Stanley New York, NY38.7MShares$6.85 Billion0.56% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $313B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...